Congress Presses FDA on Psychedelic Therapy ApprovalsWASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA ...
TerrAscend Reports Q1 2026 Financial ResultsTORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, ...
Trulieve Reports Q1 2026 Financial ResultsTALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent ...
HCN News Team2026-05-05T03:22:23-08:00Hall of Flowers Relocates Northern California Event to Sacramento
HCN News Team2026-04-21T05:09:47-08:00Oklahoma Law Review Claims 280E No Longer Applies Post-Cannabis Rescheduling
HCN News Team2026-04-06T14:39:02-08:00Stündenglass Partners with Be$os for Culture-Driven Collaboration
HCN News Team2026-02-10T17:50:55-08:00Enter the Garden: Inside Spiritual Plants’ Routine-Friendly Path to Plant Medicine
HCN News Team2026-04-07T03:50:31-08:00Vireo Growth and MWBE-Led Ace Venture Announce Strategic Partnership
HCN News Team2026-03-04T05:30:02-08:00Los Angeles City Council Advances a Tax Amnesty Program for Licensed Cannabis Businesses
HCN News Team2026-05-01T05:24:07-08:00Allied Market Research: Global Cannabis Market to Generate $149B by 2031
HCN News Team2026-02-13T16:14:16-08:00ANNOUNCING: ‘Future of Cannabis’ with Guy Rocourt Returns With Fresh Conversations on the Next Chapter of Cannabis
HCN News Team2025-10-05T14:49:11-08:00France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
HCN News Team2025-07-10T11:13:04-08:00Clampdown on Australian Medicinal Cannabis Prescribing Raises Questions on Effectiveness
HCN News Team2026-05-05T05:29:50-08:00Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
HCN News Team2026-04-29T03:15:25-08:00Helus Pharma Teams Up with TARA Mind on Veteran Mental Health Efforts
HCN News Team2026-04-22T04:58:35-08:00AtaiBeckley Reports Expanded Phase 2a Data for EMP-01 in Social Anxiety Disorder